Syft Technologies has been awarded a $3m FRST RFI grant to continue their medical research programme
Syft has again successfully secured a four year grant totaling over $3M dollars from the Foundation for Research Science and Technology’s Research for Industry (RFI) programme.
Syft’s medical strategy director, Dr Jenny Scotter says: “The announcement of this funding is exciting on a number of levels; it will allow us to continue developing our portfolio of medical applications in collaboration with our external research teams including The University of Otago Medical School and the Canterbury DHB, which aligns perfectly with our commercial partnering strategy.”
Syft have also recently been certified under the ISO 13485 quality system, a stringent set of business processes specifically required for the design, manufacture and sale of instrumentation into the lucrative medical diagnostics industry. To date, only a small handful of NZ companies have achieved this exacting quality standard.
Syft Chief Executive Geoff Peck commenting on having achieved certification said: "For a small and growing company, having robust business practices across the company is a vital component in our journey towards FDA approval and subsequent success in the medical sector. Our ability to reach the standards set out by ISO 13485 is testament to the quality of our team, their research and our processes."
Most read news
Organizations
Other news from the department business & finance

Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.